Getting a call from your civil surgeon’s office about a "reactive" result can be alarming, especially in the middle of an immigration case. But a reactive RPR on Form I-693 is a screening result, not a final diagnosis, and it is not, by itself, a reason your green card or adjustment of status application gets denied. Understanding what the test actually measures, and what has to happen after a reactive result, takes most of the fear out of the process.
What the RPR Test Actually Screens For
The RPR (Rapid Plasma Reagin) test is one of the standard blood screens a civil surgeon runs as part of the I-693 medical examination. It is a nontreponemal test, meaning it does not look for the syphilis bacterium itself. Instead, it detects certain antibodies the body produces in response to tissue damage that syphilis infection can cause. That makes RPR a fast, inexpensive first-line screen, but also one that can occasionally react to other conditions unrelated to syphilis, which is why a reactive result is never treated as a stand-alone diagnosis.
When an RPR comes back reactive, the civil surgeon reports a quantitative titer, a ratio such as 1:4 or 1:8, and documents it on Form I-693. That number matters later for tracking whether treatment is working, but on its own it does not determine your immigration outcome.
Reactive Doesn’t Mean Disqualified: The Confirmatory Test
A reactive RPR triggers a second, more specific blood test called a treponemal test. Depending on the lab a clinic uses, this may be labeled TP-PA, TPHA, EIA, or CIA. Unlike RPR, a treponemal test looks for antibodies specific to the syphilis bacterium itself, which is why it functions as the confirmatory step.
- Reactive RPR + reactive treponemal test: syphilis infection is confirmed, and the applicant is classified as a Class A condition on Form I-693 until treatment is completed.
- Reactive RPR + nonreactive treponemal test: the RPR reaction is considered a false positive for syphilis, and no syphilis-related classification is applied.
A Class A classification is not a permanent bar. It means the case cannot move forward on the health ground until the applicant is treated, which is a temporary and well-defined obstacle rather than a dead end.
From Class A to Class B: What Treatment Changes
Once syphilis is confirmed, treatment is straightforward for the vast majority of applicants: a course of antibiotics, typically penicillin, with the dosage and duration set by the stage of infection. After treatment is completed and documented, the civil surgeon updates the classification from Class A to Class B. A Class B notation means there is a history of syphilis on record, but the applicant is no longer considered a public health risk, and it does not block approval of the case.
The paperwork trail matters here. Applicants should keep every record connected to the diagnosis and treatment, including the original lab report, the treatment plan, and written confirmation from the treating provider that the course was completed. Civil surgeons rely on this documentation to finalize the reclassification on Form I-693, and it can also matter if questions come up later in the adjudication process.
Gonorrhea Testing: Who Gets Screened
Syphilis and gonorrhea screening are grouped together in this part of the I-693 exam because both are communicable diseases of public health significance under the same regulatory framework, but the testing approach differs. Gonorrhea screening at the civil surgeon’s office is generally required for applicants between 18 and 24 years old, with testing outside that age range typically triggered only by symptoms or a documented history rather than applied automatically. Unlike the syphilis screen, gonorrhea testing is usually done through a urine sample or a swab rather than a blood draw.
A positive gonorrhea result follows the same logic as syphilis: it produces a temporary Class A classification, treatment with antibiotics resolves the infection, and the civil surgeon then reclassifies the finding as Class B once treatment is confirmed complete. It is not, on its own, a reason for denial once properly treated and documented.
| Step | Syphilis (RPR pathway) | Gonorrhea |
|---|---|---|
| Who is tested | All applicants subject to the exam’s standard blood panel | Generally applicants aged 18–24; others if symptomatic or history suggests it |
| Screening method | RPR blood test (nontreponemal) | Urine or swab test |
| Confirmation step | Treponemal test (TP-PA, TPHA, EIA, or CIA) | Clinical correlation with symptoms/history |
| If positive | Antibiotic treatment, usually penicillin | Antibiotic treatment, often a single injection |
| Classification path | Class A until treated, then Class B | Class A until treated, then Class B |
What This Means for Your Case
The practical takeaway is that a reactive RPR is the start of a defined clinical process, not the end of an immigration case. The steps are predictable: confirmatory testing to rule out a false positive, treatment if the infection is confirmed, and reclassification once treatment is documented. Applicants who stay in close contact with their civil surgeon, complete any prescribed treatment on schedule, and hold on to every piece of testing and treatment documentation put themselves in the best position to move forward without unnecessary delay. If a reactive result comes up during your exam, the right move is to ask the civil surgeon directly what the confirmatory test showed and what documentation they will need to finalize your Form I-693.